VoICE Immunization Evidence

Cost-effectiveness analysis of universal maternal immunization with Tdap vaccine in Brazil

Authored by: Sartori AMC, de Soarez PC, Fernandes EG et al.

Appears in:

Key Concept

Key Evidence: In Brazil, where pertussis cases have climbed, mainly in infants <4 months of age, vaccinating pregnant women with Tdap vaccine at the same coverage rate as influenza vaccination in pregnant women (57%) would reduce pertussis cases in children under 1 year of age by 41%, deaths by 43%, and would be cost-effective, according to the WHO thresholds.

Published In

Sartori AMC, de Soarez PC, Fernandes EG et al. 2016. Cost-effectiveness analysis of universal maternal immunization with Tdap vaccine in Brazil. Vaccine. 34.

Disease or Vaccine